🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 23 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 30/05/2012 | 44,72 | 45,10 | 44,21 | 44,72 | -0,22% | 1,99% | 849.100 |
| 29/05/2012 | 44,42 | 44,92 | 44,42 | 44,82 | +1,75% | 1,13% | 579.700 |
| 25/05/2012 | 42,52 | 44,16 | 42,52 | 44,05 | +3,23% | 3,86% | 608.700 |
| 24/05/2012 | 42,67 | 43,00 | 42,21 | 42,67 | +0,35% | 1,85% | 807.600 |
| 23/05/2012 | 42,50 | 42,68 | 41,86 | 42,52 | -0,47% | 1,93% | 588.000 |
| 22/05/2012 | 43,36 | 43,80 | 42,55 | 42,72 | -1,27% | 2,88% | 796.000 |
| 21/05/2012 | 41,82 | 43,41 | 41,75 | 43,27 | +3,91% | 3,97% | 962.700 |
| 18/05/2012 | 42,21 | 42,38 | 41,55 | 41,64 | -1,07% | 1,97% | 597.300 |
| 17/05/2012 | 42,75 | 42,84 | 42,06 | 42,09 | -1,50% | 1,82% | 635.800 |
| 16/05/2012 | 43,08 | 43,34 | 42,60 | 42,73 | -0,35% | 1,72% | 503.200 |
| 15/05/2012 | 42,96 | 43,33 | 42,60 | 42,88 | +0,26% | 1,70% | 581.000 |
| 14/05/2012 | 42,22 | 42,92 | 41,71 | 42,77 | +0,45% | 2,87% | 670.100 |
| 11/05/2012 | 42,02 | 42,87 | 42,00 | 42,58 | +0,73% | 2,07% | 734.900 |
| 10/05/2012 | 42,90 | 42,96 | 42,15 | 42,27 | -0,89% | 1,89% | 515.000 |
| 09/05/2012 | 42,70 | 42,98 | 42,49 | 42,65 | -1,07% | 1,15% | 529.200 |
| 08/05/2012 | 42,29 | 43,13 | 42,21 | 43,11 | +1,44% | 2,18% | 672.000 |
| 07/05/2012 | 42,10 | 43,10 | 41,95 | 42,50 | +0,73% | 2,73% | 771.000 |
| 04/05/2012 | 43,89 | 43,92 | 42,15 | 42,19 | -4,00% | 4,03% | 744.200 |
| 03/05/2012 | 43,73 | 44,35 | 43,73 | 43,95 | +0,66% | 1,42% | 822.800 |
| 02/05/2012 | 43,41 | 43,99 | 43,29 | 43,66 | +0,25% | 1,61% | 624.900 |
| 01/05/2012 | 43,99 | 44,10 | 43,19 | 43,55 | -0,46% | 2,07% | 865.600 |
| 30/04/2012 | 44,25 | 44,47 | 43,31 | 43,75 | -2,69% | 2,62% | 1.374.400 |
| 27/04/2012 | 41,42 | 45,01 | 41,42 | 44,96 | +0,94% | 8,67% | 998.000 |
| 26/04/2012 | 43,23 | 44,90 | 41,77 | 44,54 | +3,27% | 7,24% | 1.619.500 |
| 25/04/2012 | 42,52 | 43,17 | 42,44 | 43,13 | +2,52% | 1,72% | 694.000 |
| 24/04/2012 | 42,06 | 42,45 | 41,79 | 42,07 | -0,26% | 1,57% | 669.500 |
| 23/04/2012 | 41,75 | 42,27 | 41,42 | 42,18 | +0,21% | 2,04% | 687.400 |
| 20/04/2012 | 41,90 | 42,40 | 41,58 | 42,09 | +0,91% | 1,96% | 921.700 |
| 19/04/2012 | 40,65 | 42,15 | 40,65 | 41,71 | +3,19% | 3,69% | 1.262.800 |
| 18/04/2012 | 41,01 | 41,47 | 40,34 | 40,42 | -1,77% | 2,76% | 1.290.500 |